SCHEMBL5236350

SCHEMBL5236350

CC(C)CCOC(=O)C1(C(=O)O)CC(OCc2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.43
BCHE P06276 3/20 0.39
EPHX2 P34913 1/20 0.37
ALDH1A1 P00352 6/20 0.37
CYP3A4 P08684 6/20 0.37
TSHR P16473 6/20 0.37
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
BDKRB2 P30411 1/20 0.37
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSK P43235 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 2/20 0.36
CYP2C9 P11712 4/20 0.36
CYP2C19 P33261 3/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231539 0.85 PPARG (0.37) PPARGBCHEEPHX2ALDH1A1CYP3A4
SCHEMBL8053435 0.84 ADAM17 (0.45) EPHX2ALDH1A1CYP3A4TSHRMAPK1
Hydrochloric Acid SCHEMBL8049068 0.83 ADAM17 (0.44) EPHX2ALDH1A1CYP3A4TSHRMAPK1
SCHEMBL28699610 0.83 TSHR (0.43) BCHEEPHX2ALDH1A1CYP3A4TSHR
SCHEMBL5236909 0.82 PPARG (0.40) PPARGBCHEEPHX2ALDH1A1CYP3A4
SCHEMBL5236919 0.82 PPARG (0.40) PPARGBCHEEPHX2ALDH1A1CYP3A4
SCHEMBL32676611 0.81 EPHX2 (0.44) BCHEEPHX2ALDH1A1CYP3A4CTSL
SCHEMBL2640274 0.80 EPHX2 (0.47) BCHEEPHX2ALDH1A1MAPK1L3MBTL1
SCHEMBL871442 0.78 ADAM17 (0.46) EPHX2ALDH1A1CYP3A4TSHRMAPK1
SCHEMBL5235374 0.78 KLK7 (0.40) PPARGEPHX2L3MBTL1CTSLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0990654-B1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2007-11-14 EP disclosed
US-6448266-B1 COMPOUNDS SUCH AS 2-AMINO-7-(3-(3-AMINO-1-FLUOROCYCLOBUTAN-3-YL)PYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUORO-1-CYCLOPROPYL)-8-METHYL-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS, PNEUMOCOCCUS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-09-10 US disclosed
EP-0990654-A1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed